B. Celli and W. Macnee, Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, European Respiratory Journal, vol.23, issue.6, pp.932-946, 2004.
DOI : 10.1183/09031936.04.00014304

O. Minai, A. Chaouat, and S. Adnot, Pulmonary Hypertension in COPD: Epidemiology, Significance, and Management, Chest, vol.137, issue.6, pp.39-51, 2010.
DOI : 10.1378/chest.10-0087

S. Santos, V. Peinado, J. Ramirez, T. Melgosa, J. Roca et al., Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD, European Respiratory Journal, vol.19, issue.4, pp.632-638, 2002.
DOI : 10.1183/09031936.02.00245902

L. Savale, A. Chaouat, S. Bastuji-garin, M. E. Boyer, L. Maitre et al., Shortened Telomeres in Circulating Leukocytes of Patients with Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.7, pp.566-571, 2009.
DOI : 10.1164/rccm.200809-1398OC
URL : https://hal.archives-ouvertes.fr/inserm-00374870

J. Campisi, Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors, Cell, vol.120, issue.4, pp.513-522, 2005.
DOI : 10.1016/j.cell.2005.02.003

N. Mathon and A. Lloyd, MILESTONES IN CELL DIVISION CELL SENESCENCE AND CANCER, Nature Reviews Cancer, vol.1, issue.3, pp.203-213, 2001.
DOI : 10.1038/35106045

C. Beausejour, A. Krtolica, F. Galimi, M. Narita, S. Lowe et al., Reversal of human cellular senescence: roles of the p53 and p16 pathways, The EMBO Journal, vol.22, issue.16, pp.4212-4222, 2003.
DOI : 10.1093/emboj/cdg417

T. Kuilman and D. Peeper, Senescence-messaging secretome: SMS-ing cellular stress, Nature Reviews Cancer, vol.46, issue.2, pp.81-94, 2009.
DOI : 10.1111/j.1474-9728.2004.00129.x

J. Coppe, P. Desprez, A. Krtolica, and J. Campisi, The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression, Annual Review of Pathology: Mechanisms of Disease, vol.5, issue.1, pp.99-118, 2009.
DOI : 10.1146/annurev-pathol-121808-102144

C. Matthews, I. Gorenne, S. Scott, N. Figg, P. Kirkpatrick et al., Vascular Smooth Muscle Cells Undergo Telomere-Based Senescence in Human Atherosclerosis: Effects of Telomerase and Oxidative Stress, Circulation Research, vol.99, issue.2, pp.156-164, 2006.
DOI : 10.1161/01.RES.0000233315.38086.bc

T. Tsuji, K. Aoshiba, A. A. Nagai, L. Savale, C. Chouaid et al., Alveolar cell senescence in patients with pulmonary emphysema Role for Interleukin-6 in COPD- Related Pulmonary Hypertension Short telomeres are a risk factor for idiopathic pulmonary fibrosis, Am J Respir Crit Care Med. Proc Natl Acad Sci, vol.174105, issue.1335, pp.886-89313051, 2006.

C. Murry, C. Gipaya, T. Bartosek, E. Benditt, and S. Schwartz, Monoclonality of smooth muscle cells in human atherosclerosis, Am J Pathol, vol.151, issue.3, pp.697-705, 1997.

T. Minamino, H. Miyauchi, T. Yoshida, Y. Ishida, H. Yoshida et al., Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction, Circulation, vol.105, issue.13, pp.1541-1544, 2002.
DOI : 10.1161/01.CIR.0000013836.85741.17

T. Nyunoya, M. Monick, A. Klingelhutz, H. Glaser, J. Cagley et al., Cigarette smoke induces cellular senescence via Werner's syndrome protein down-regulation Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging, Am J Respir Crit Care Med. Proc Natl Acad Sci U S A, vol.17998, issue.421, pp.279-28712072, 2001.

O. Sanchez, M. E. Perros, F. Fadel, E. Tu, L. Humbert et al., Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.10, pp.1041-1047, 2007.
DOI : 10.1164/rccm.200610-1559OC

E. Soon, A. Holmes, C. Treacy, N. Doughty, L. Southgate et al., Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension, Circulation, vol.122, issue.9, pp.920-927, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.933762

J. Cronkhite, C. Xing, G. Raghu, K. Chin, F. Torres et al., Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.7, pp.729-737, 2008.
DOI : 10.1164/rccm.200804-550OC

O. Fig and I. , Comparison of pulmonary artery pressure, pulmonary capillary wedge pressure, pulmonary vascular resistance, and right atrial pressure between patients dichotomized based on the median telomere length. Values are means±SEM. *P<0.05, **P<0.01 compared with values from subjects with telomere lengths less than or equal to 0.6. Telomere length is expressed as the T/S ratio of the telomere repeat copy number over the single-gene copy number, pp.2-33, 2011.

O. Figure and I. , Telomere length and Western blotting analysis of p16, p53, and p21 protein levels in PA-SMCs from the 14 patients with COPD and 13 controls determined at passage 2 and at senescence. Each bar is the mean±SEM. *P<0.01 compared with values for PA-SMCs from controls, P<0.05 compared with corresponding values for PA-SMCs at passage 2. CIRCRESAHA, pp.2-34, 2011.

L. Savale, C. Chouaid, L. Tu, B. Sztrymf, M. Canuet et al., Role for Interleukin-6 in COPD- Related Pulmonary Hypertension, Chest, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00596924

G. Gary-bobo, A. Houssaini, V. Amsellem, D. Rideau, P. Pacaud et al., Effects of HIV Protease Inhibitors on Progression of Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension in Rats, Circulation, vol.122, issue.19, pp.1937-1947, 2010.
DOI : 10.1161/CIRCULATIONAHA.110.973750
URL : https://hal.archives-ouvertes.fr/inserm-00545885

S. Eddahibi, M. Humbert, E. Fadel, B. Raffestin, M. Darmon et al., Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension, Journal of Clinical Investigation, vol.108, issue.8, pp.1141-1150, 2001.
DOI : 10.1172/JCI200112805

R. Cawthon, Telomere measurement by quantitative PCR, Nucleic Acids Research, vol.30, issue.10, p.47, 2002.
DOI : 10.1093/nar/30.10.e47

M. Pascaud, S. Eddahibi, B. Raffestin, P. Yeh, F. Griscelli et al., Lung overexpression of the anti-angiogenic factor angiostatin aggravates pulmonary hypertension in hypoxic mice, American of Journal Respiratory and Critical Care Medicine, vol.163, p.119, 2001.